HRADILEK, Pavel, Olga ZAPLETALOVA, Petra HANULIKOVA, Eva KUBALA HAVRDOVA, Ivana WOZNICOVA, Aneta MAZOUCHOVA, Jiri DRAHOTA, Michal LAUER, Ivana STETKAROVA, Martin VALIS, Jana LIBERTINOVA, Pavel ŠTOURAČ, Jana ADAMKOVA, Radek AMPAPA, Marta VACHOVA, Michal DUFEK, Alena MARTINKOVA, Marek PETERKA, Eva RECMANOVA, Jan MARES and Dana HORAKOVA. Is breastfeeding in MS harmful or not? An answer from real-world Czech data. MULTIPLE SCLEROSIS AND RELATED DISORDERS. OXFORD: ELSEVIER SCI LTD, 2023, vol. 76, August 2023, p. 1-7. ISSN 2211-0348. Available from: https://dx.doi.org/10.1016/j.msard.2023.104790.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Is breastfeeding in MS harmful or not? An answer from real-world Czech data
Authors HRADILEK, Pavel (203 Czech Republic), Olga ZAPLETALOVA (203 Czech Republic), Petra HANULIKOVA (203 Czech Republic), Eva KUBALA HAVRDOVA (203 Czech Republic), Ivana WOZNICOVA (203 Czech Republic), Aneta MAZOUCHOVA (203 Czech Republic), Jiri DRAHOTA (203 Czech Republic), Michal LAUER (203 Czech Republic), Ivana STETKAROVA (203 Czech Republic), Martin VALIS (203 Czech Republic), Jana LIBERTINOVA (203 Czech Republic), Pavel ŠTOURAČ (203 Czech Republic, belonging to the institution), Jana ADAMKOVA (203 Czech Republic), Radek AMPAPA (203 Czech Republic), Marta VACHOVA (203 Czech Republic), Michal DUFEK (203 Czech Republic), Alena MARTINKOVA (203 Czech Republic), Marek PETERKA (203 Czech Republic), Eva RECMANOVA (203 Czech Republic), Jan MARES (203 Czech Republic) and Dana HORAKOVA (203 Czech Republic).
Edition MULTIPLE SCLEROSIS AND RELATED DISORDERS, OXFORD, ELSEVIER SCI LTD, 2023, 2211-0348.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30210 Clinical neurology
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 4.000 in 2022
RIV identification code RIV/00216224:14110/23:00133298
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1016/j.msard.2023.104790
UT WoS 001032690900001
Keywords in English Multiple sclerosis; Breastfeeding; EDSS; Relapses; Czech national multiple sclerosis patient registry ReMuS
Tags 14110221, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 29/1/2024 14:33.
Abstract
Introduction: The influence of breastfeeding and it & PRIME;s duration on the course of multiple sclerosis (MS) is unclear. Here we analyzed a real-world data for breastfeeding women with MS and their disease course collected from a Czech national registry ReMuS.Objectives: To identify risk factors associated with not initiating breastfeeding after delivery, to analyze the impact of breastfeeding on the MS disease course, evaluate the assumption, that breastfeeding is not harmful in MS patients, and compare the disease course by breastfeeding status.Materials and methods: Using propensity score matching we compared Expanded Disability Status Scale (EDSS), confirmed disease worsening (CDW) and annual relapse rate (ARR) in breastfeeding and non-breastfeeding MS patients according to disease duration, disease modifying treatment (DMT) before pregnancy, last EDSS score before conception, age, and ARR during pregnancy. We also compared these parameters between breastfeeding patients not using a DMT and non-breastfeeding patients who resumed DMT within 3 months after delivery. EDSS, ARR, and CDW were collected at 12, 24, and 36 months after delivery.Results: A total of 1681 pregnancies that ended in delivery were analyzed from 2013 through 2020. Change in ARR and EDSS values and 6-months CDW did not significantly differ between the analyzed groups. Compared with non-breastfeeding women who resumed DMT early after delivery, breastfeeding women with MS did not experience worse clinical outcomes even without initiating a DMT. Discussion: Breastfeeding in Czech women with MS did not negatively affect the disease course and can be supported. Patients with MS can be treated with certain DMTs alongside breastfeeding and there is no need to stop breastfeeding, if the patient is clinically stable.
PrintDisplayed: 22/7/2024 16:22